Optimising the management of HR+ HER2- metastatic breast cancer - Case discussions on first- and further-line treatment strategies, and targeting HER2
| Event title | Event dates | Event venue | Website of the event | Main speciality | Name of the CME provider | Amount of ECMEC® credits |
|---|---|---|---|---|---|---|
| Optimising the management of HR+ HER2- metastatic breast cancer - Case discussions on first- and further-line treatment strategies, and targeting HER2 | 22/01/2025 - 22/01/2025 | Belgium, Virtual | Website | Oncology | ISSECAM IVZW | 1.0 European CME credits (ECMEC®) |
